OBaris raises €158K Seed round

The funding will be used to validate the regulatory strategy, initiate the first meeting with the FDA, organize scale-up manufacturing, and further prepare for fundraising by meeting with international investors. It will also be used to complete product optimization and Phase 1A of clinical trials for their drug product.

Source: https://www.venturekick.ch/OBaris-obtains-the-CHF-150000-Kick-to-enable-the-painless-delivery-of-injectable-drugs